T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,939,919 shares of PRCT stock, worth $195 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,939,919
Previous 3,695,027
20.44%
Holding current value
$195 Million
Previous $155 Million
6.18%
% of portfolio
0.09%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$354 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$282 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$219 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$132 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.57MShares$104 Million0.46% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.96B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...